TGF-βRI kinase activity mediates Emdogain-stimulated in vitro osteoclastogenesis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TGF-βRI kinase activity mediates Emdogain-stimulated in vitro osteoclastogenesis
Authors
Keywords
Emdogain, Enamel matrix derivative, Osteoclast, TGF-β, Differentiation, SB431542, SIS3, Bone marrow
Journal
Clinical Oral Investigations
Volume 18, Issue 6, Pages 1639-1646
Publisher
Springer Nature
Online
2013-11-12
DOI
10.1007/s00784-013-1129-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone
- (2013) Zhiyuan Lou et al. MEDICAL ONCOLOGY
- Enamel Matrix Derivative Inhibits Adipocyte Differentiation of 3T3-L1 Cells via Activation of TGF-βRI Kinase Activity
- (2013) Reinhard Gruber et al. PLoS One
- Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts
- (2012) Kenji Sakoda et al. EUROPEAN JOURNAL OF ORAL SCIENCES
- Pathways for Bone Loss in Inflammatory Disease
- (2012) Tobias Braun et al. Current Osteoporosis Reports
- Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6
- (2011) Tetsuro Yasui et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways
- (2011) Muzaffer Cicek et al. PLoS One
- Enamel Matrix Derivative: A Review of Cellular Effects In Vitro and a Model of Molecular Arrangement and Functioning
- (2011) H. Michelle Grandin et al. TISSUE ENGINEERING PART B-REVIEWS
- Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo
- (2010) James R Edwards et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Enhancement of Bone Morphogenetic Protein-2-Induced Ectopic Bone Formation by Transforming Growth Factor-β1
- (2010) Keita Tachi et al. TISSUE ENGINEERING PART A
- In vivo Application of Amelogenin Suppresses Root Resorption
- (2009) Y. Yagi et al. JOURNAL OF DENTAL RESEARCH
- Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
- (2009) Khalid S. Mohammad et al. PLoS One
- Amelogenin binds to both heparan sulfate and bone morphogenetic protein 2 and pharmacologically suppresses the effect of noggin
- (2008) Kan Saito et al. BONE
- Evaluating Emdogain®and healing of replanted teeth using an intra-individual experimental–control study design
- (2008) Margareta Fridström et al. DENTAL TRAUMATOLOGY
- Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels
- (2008) Dieter D. Bosshardt JOURNAL OF CLINICAL PERIODONTOLOGY
- The Suppressive Effect of Enamel Matrix Derivative on Osteocalcin Gene Expression of Osteoblasts Is Neutralized by an Antibody Against TGF-β
- (2008) Yoshiyuki Wada et al. JOURNAL OF PERIODONTOLOGY
- Transforming growth factor-β enables NFATc1 expression during osteoclastogenesis
- (2007) S.W. Fox et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibitory effect of enamel matrix derivative on osteoblastic differentiation of rat calvaria cells in culture
- (2007) Hideki Hama et al. JOURNAL OF PERIODONTAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started